Sort
40,608 grants matching “prostate cancer”
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2015 · CA
Defining Response and Resistance to PI3K and AR inhibition in Prostate Cancer
$439,351Brett Stewart Carver · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Mechanisms of De Novo Methylation in Cancer
$439,342Peter A Jones · University Of Southern California · R37 · FY2012 · CA
Development of PDE5 Inhibitors for Localized Delivery to Prevent Colorectal Cancer
$439,332Shaobin Miao · Augusta University · R15 · FY2021 · CA
Development of Methods for a Simplified and Reliable Prostate Cancer MRI Exam
$439,314Stephan E Maier · Brigham And Women'S Hospital · R01 · FY2024 · CA
Development of cancer therapeutic TBK1/IKKi dual inhibitors
$439,200Jun-Li Luo · Scripps Florida · R01 · FY2018 · CA
Development of cancer therapeutic TBK1/IKKi dual inhibitors
$439,200Jun-Li Luo · Scripps Florida · R01 · FY2017 · CA
Development of cancer therapeutic TBK1/IKKi dual inhibitors
$439,200Jun-Li Luo · Scripps Florida · R01 · FY2016 · CA
Development of cancer therapeutic TBK1/IKKi dual inhibitors
$439,200Jun-Li Luo · Scripps Florida · R01 · FY2020 · CA
The Allee Effect in Tumor Initiation
$439,171Amy Brock · University Of Texas At Austin · R01 · FY2022 · CA
The role of amphiregulin in mediating radiation cystitis in cancer survivors
$439,160Bernadette Margaretha Maria Zwaans · William Beaumont Hospital Research Inst · R01 · FY2023 · DK
Core 2: Biospecimen/Pathology Core
$439,158Lakshmi Priya Kunju · University Of Michigan At Ann Arbor · P50 · FY2025 · CA
Structure meets function for OATP1B1, a transporter involved in the uptake of endogenous and xenobiotic materials and drugs
$439,154Aviv Paz · Hauptman-Woodward Medical Research Inst · R01 · FY2024 · GM
Project 1
$439,152James L Mohler · Univ Of North Carolina Chapel Hill · P01 · FY2008 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$439,130Hendrik Luesch · University Of Florida · R01 · FY2020 · CA
Novel Targeted Anticancer Agents from Marine Cyanobacteria
$439,130Hendrik Luesch · University Of Florida · R01 · FY2021 · CA
Etiologic Studies of Prostate Cancer
$439,110Demetrius Albanes · Division Of Cancer Epidemiology And Genetics · ZIA · FY2017 · CA
Energetic Factors, Lethal Prostate Cancer, and Survivorship
$439,071Jing Ma · Harvard School Of Public Health · U54 · FY2012 · CA
SUPERHYDROPHOBIC DRUG LOADED BUTTRESSES FOR PREVENTION OF LUNG TUMOR RECURRENCE
$439,002Mark W Grinstaff · Boston University (Charles River Campus) · R01 · FY2020 · CA
Admin Core
$438,972Maria F Lima · Meharry Medical College · U54 · FY2021 · MD
The RCMI Program in Health Disparities Research at Meharry Medical College
$438,972Samuel E. Adunyah · Meharry Medical College · U54 · FY2021 · MD
BIOMOLECULAR ANALYSIS USING LIQUID CRYSTALS
$438,944Nicholas L Abbott · University Of Wisconsin-Madison · R01 · FY2010 · CA
Imaging Habitats in Sarcoma
$438,929Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
Imaging Habitats in Sarcoma
$438,929Robert J Gillies · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2016 · CA
Mechanism of beta-Catenin and APC-Regulated Transcription at Wnt Target Genes
$438,719Katherine A Jones · Salk Institute For Biological Studies · R01 · FY2014 · CA